EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Recent advances of bioresponsive polymeric nanomedicine for cancer therapy

Tu Hong, Xinyuan Shen, Madiha Zahra Syeda, Yang Zhang, Haonan Sheng, Yipeng Zhou, JinMing Xu, Chaojie Zhu, Hongjun Li, Zhen Gu, Longguang Tang

Nano Research · 2023-02 · 16 (2) · 2660-2671

DOI: 10.1007/s12274-022-5002-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nano Research, online erschienen am 15.11.2022. Verfasst von Tu Hong und 10 weiteren Autor:innen. Beteiligte Einrichtung: International institutes of Medicine, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, 322000 China. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A bioresponsive polymeric nanocarrier for drug delivery is able to alter its physical and physicochemical properties in response to a variety of biological signals and pathological changes, and can exert its therapeutic efficacy within a confined space. These nanosystems can optimize the biodistribution and subcellular location of therapeutics by exploiting the differences in biochemical properties between tumors and normal tissues. Moreover, bioresponsive polymer-based nanosystems could be rationally designed as precision therapeutic platforms by optimizing the combination of responsive elements and therapeutic components according to the patient-specific disease type and stage. In this review, recent advances in smart bioresponsive polymeric nanosystems for cancer chemotherapy and immunotherapy will be summarized. We mainly discuss three categories, including acidity-sensitive, redox-responsive, and enzyme-triggered polymeric nanosystems. The important issues regarding clinical translation such as reproducibility, manufacture, and probable toxicity, are also commented.

Schlagwörter

Stichwörter der Autor:innen

bioresponsivecancer therapydrug deliveryimmunotherapypolymer

Autor:innen und Institutionen

  • International institutes of Medicine, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, 322000 China.
  • Key Laboratory of Advanced Drug Delivery Systems of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058 China.
  • Shanghai Jiaotong University School of Medicine, Shanghai, 200025 China.
  • Department of Thoracic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310006 China.
  • Department of Hepatobiliary and Pancreatic Surgery the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009 China.
  • Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121 China.

Zitieren

APA

Hong, T., Shen, X., Syeda, M. Z., Zhang, Y., Sheng, H., Zhou, Y., Xu, J., Zhu, C., Li, H., Gu, Z., & Tang, L. (2023). Recent advances of bioresponsive polymeric nanomedicine for cancer therapy. Nano Research, 16(2), 2660-2671. https://doi.org/10.1007/s12274-022-5002-2

Vancouver

Hong T, Shen X, Syeda MZ, Zhang Y, Sheng H, Zhou Y, et al. Recent advances of bioresponsive polymeric nanomedicine for cancer therapy. Nano Research. 2023;16(2):2660-2671. doi:10.1007/s12274-022-5002-2

BibTeX
@article{Hong2023,
  author = {Hong, Tu and Shen, Xinyuan and Syeda, Madiha Zahra and Zhang, Yang and Sheng, Haonan and Zhou, Yipeng and Xu, JinMing and Zhu, Chaojie and Li, Hongjun and Gu, Zhen and Tang, Longguang},
  title = {Recent advances of bioresponsive polymeric nanomedicine for cancer therapy},
  journal = {Nano Research},
  year = {2023},
  volume = {16},
  number = {2},
  pages = {2660--2671},
  doi = {10.1007/s12274-022-5002-2}
}
Kostenlos starten →